During the past decade, Lexington Cardiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lexington Cardiology" #1 collaborator was "BTG International Inc." with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Sorin CRM" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Lexington Cardiology" are "Aortic Valve Stenosis" (1 trials), "Atrial Fibrillation" (1 trials), "Bradycardia" (1 trials), "Heart Disease" (1 trials) and "Heart Failure NYHA Class III and Ambulatory IV" (1 trials). Many other conditions were trialed in "Lexington Cardiology" in a lesser frequency.

Most popular intervention types in "Lexington Cardiology" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Cardiac Rhythm Management device" (1 trials), "EkoSonic Endovascular System with thrombolytic" (1 trials), "PARADYM RF SONR" (1 trials), "TAVR" (1 trials) and "WATCHMAN" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lexington Cardiology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Lexington Cardiology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Lexington Cardiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lexington Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".